COVID-19 and pregnancy: An umbrella review of clinical presentation, vertical transmission, and maternal and perinatal outcomes

A Ciapponi, A Bardach, D Comandé, M Berrueta… - PloS one, 2021 - journals.plos.org
Background We conducted an overview of systematic reviews (SRs) summarizing the best
evidence regarding the effect of COVID-19 on maternal and child health following Cochrane …

N-acetylcysteine as adjuvant therapy for COVID-19–a perspective on the current state of the evidence

KK Wong, SWH Lee, KP Kua - Journal of inflammation research, 2021 - Taylor & Francis
The looming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
long-lasting pandemic of coronavirus disease 2019 (COVID-19) around the globe with …

D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with …

A Poudel, Y Poudel, A Adhikari, BB Aryal, D Dangol… - Plos one, 2021 - journals.plos.org
Introduction Coronavirus Disease 2019 is a primarily respiratory illness that can cause
thrombotic disorders. Elevation of D-dimer is a potential biomarker for poor prognosis in …

Elevated plasma fibrinogen is associated with excessive inflammation and disease severity in COVID-19 patients

J Sui, DF Noubouossie, S Gandotra… - Frontiers in cellular and …, 2021 - frontiersin.org
Background The coronavirus disease-19 (COVID-19) is characterized with intense
inflammatory response, cardiac involvement, and coagulopathy. Fibrinogen, as a biomarker …

Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: A prospective multi-center cohort study

M Elhadi, A Alsoufi, A Abusalama, A Alkaseek… - Plos one, 2021 - journals.plos.org
Background The coronavirus disease (COVID-19) pandemic has severely affected African
countries, specifically the countries, such as Libya, that are in constant conflict. Clinical and …

Hemostatic system (Fibrinogen level, D-Dimer, and FDP) in severe and Non-Severe patients With COVID-19: a systematic review and meta-Analysis

R Mehrdad, K Zahra… - Clinical and Applied …, 2021 - journals.sagepub.com
SARS-CoV-2 in COVID-19 triggers abnormalities in coagulation parameters that can
contribute to thrombosis. The goals of this research were to determine the levels of …

Albumin infusion in critically ill COVID-19 patients: hemodilution and anticoagulation

G Ramadori - International journal of molecular sciences, 2021 - mdpi.com
Hypercoagulation is one of the major risk factors for ICU treatment, mechanical ventilation,
and death in critically ill patients infected with SARS-CoV-2. At the same time …

The impact of COVID‐19 on the sensitivity of D‐dimer for pulmonary embolism

SJ Elberts, R Bateman, A Koutsoubis… - Academic …, 2021 - Wiley Online Library
Objective This study seeks to evaluate the test characteristics of D‐dimer for pulmonary
embolism (PE) in patients with a concurrent diagnosis of COVID‐19. We hypothesized that …

[HTML][HTML] Demographic, clinical, and laboratory characteristics of patients with COVID-19 during the second and third waves of the pandemic in Egypt

RA Eid, AM Attia, M Hassan, MA Shaker… - Journal of infection and …, 2021 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel
virus that belongs to the coronaviruses and causes coronavirus disease 2019 (COVID-19) …

[HTML][HTML] Biochemical role of serum ferratin and d-dimer parameters in COVID 19 diagnosis

A Farasani - Saudi journal of biological sciences, 2021 - Elsevier
One and one only most unforgettable pandemic is coronavirus 2019 (COVID 19) which is
the most memorable pandemic of the twenty-first century. The diagnosis of COVID19 is …